Teva, AbCellera Launch Collaboration

News   Feb 03, 2016

 
Teva, AbCellera Launch Collaboration
 
 
 

RELATED ARTICLES

Sweet Spot of Activity in Immune System Key to Fighting Cancer

News

Scientists have shown how stimulating a specific location on the surface of immune cells can be targeted with antibodies to help in their fight against cancer.

READ MORE

Compound Selectively Kills Liver Cancer Stem Cells

News

Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurrence of hepatocellular carcinoma (HCC), the most common form of liver cancer.

READ MORE

170 Potential Lung Cancer Drug Targets Identified Using Unique Cellular Library

News

After testing more than 200,000 chemical compounds, UT Southwestern’s Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE